Significance of CD99 expression in T-lineage acute lymphoblastic leukemia
- 3 August 2016
- journal article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 17 (2) , 117-123
Abstract
BACKGROUND: CD99 was first isolated as an antigen on the T acute lymphoblastic leukemia cells. It has been shown to participate in T cell adhesion and is widely expressed on a variety of hematopoietic and non-hematopoietic cell types. CD99 was firstKeywords
This publication has 10 references indexed in Scilit:
- New markers for minimal residual disease detection in acute lymphoblastic leukemiaBlood, 2011
- Modulation of antigen expression in B‐cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug‐induced regulatory phenomenon. Results of the AIEOP‐BFM‐ALL‐FLOW‐MRD‐Study GroupCytometry Part B: Clinical Cytometry, 2010
- Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: Implications for minimal residual disease detectionCytometry Part B: Clinical Cytometry, 2010
- Characterization of Acute Lymphoblastic Leukemia Subtypes in Moroccan ChildrenInternational Journal of Pediatrics, 2009
- Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemiaBritish Journal of Haematology, 2008
- Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasibleCytometry Part B: Clinical Cytometry, 2008
- CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual diseaseLeukemia, 2004
- Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium ExperienceJournal of Clinical Oncology, 2003
- TREATMENT OF ADULT ALL ACCORDING TO PROTOCOLS OF THE GERMAN MULTICENTER STUDY GROUP FOR ADULT ALL (GMALL)Hematology/Oncology Clinics of North America, 2000
- New definition of remission in childhood acute lymphoblastic leukemiaLeukemia, 2000